Vinay Prasad


Vinayak K. Prasad is an American hematologist-oncologist. He is an associate professor of medicine at the Oregon Health & Science University School of Medicine. Prasad is a noted critic on the direction of cancer research. He has developed a following using Twitter as his platform. He is also the author of multiple books, including "Ending Medical Reversal" , co-authored with Dr. Adam Cifu and "Malignant: How Bad Evidence and Bad Policy Harm People With Cancer" to be released in Spring 2020.

Early life and education

Vinay Prasad was raised in a suburb of Cleveland, Ohio before moving outside of Chicago in northern Indiana. His parents immigrated from India. Prasad has a younger brother.
He graduated from high school with straight As and was one of the 16 valedictorians. Prasad attended Michigan State University where he took courses in health care ethics and physiology. He did not initially intend to become a physician, and took the Medical College Admission Test after his roommate suggested it. In 2005, Prasad graduated summa cum laude from MSU with a double major in Philosophy and Physiology. He completed his medical degree at University of Chicago in 2009 and completed a residency in internal medicine at Northwestern University in 2012. In 2012, Prasad was certified in internal medicine by the American Board of Internal Medicine. In 2014, he earned a Master's of Public Health from Johns Hopkins University. In 2015, Prasad held a fellowship in oncology at the National Cancer Institute and hematology at the National Heart, Lung, and Blood Institute.

Career

Prasad is a hematologist-oncologist at the Oregon Health & Science University. He is part of the lymphoma team that treats patients with hematologic malignancies. Prasad is also an assistant professor of medicine. He is a noted critic on the direction of cancer research. Prasad has developed a following using Twitter and his podcast "Plenary Session". He also studies the financial conflicts in drug approvals. Prasad is a member of the American Society of Clinical Oncology.

Selected works

Articles

*